Oxidation–reductive coupling of alcohols catalyzed by oxo-vanadium complexes

2018 ◽  
Vol 54 (7) ◽  
pp. 790-793 ◽  
Author(s):  
Eric Steffensmeier ◽  
Kenneth M. Nicholas

Oxo-vanadium complexes catalyze the novel oxidation–reductive coupling of benzylic and allylic alcohols.

1998 ◽  
Vol 76 (10) ◽  
pp. 1467-1473 ◽  
Author(s):  
Veranja Karunaratne ◽  
David Dolphin

A variety of substituted 2-methylpyrroles (3-8) were oxidized using the metalloporphyrin catalysts iron(III) meso-tetra(2,6-dichloro-3-sulphonatophenyl)-β-octachloroporphyrin chloride 1 and iron(III) meso-tetra(2,6-dichlorophenyl)-β-octachloroporphyrin chloride 2 under very mild conditions. Treatment of the resulting allylic alcohols 3a-8a with α-free pyrroles 9 and 10 resulted in a very efficient synthesis of the corresponding dipyrromethanes 3b-8b and 3c-8c. Furthermore, the above allylic alcohols when treated with furfurylamine produced the novel (2-furylmethyl)-2-pyrrolylmethylamines 3d-8d.Key words: catalytic oxidation, metalloporphyrins, pyrroles, dipyrromethanes, polyhalogenated porphyrins.


2003 ◽  
Vol 5 (5) ◽  
pp. 653-655 ◽  
Author(s):  
Kazuhiko Takai ◽  
Shuji Sakamoto ◽  
Takahiko Isshiki

2019 ◽  
Vol 4 (1) ◽  
pp. 47-54 ◽  
Author(s):  
Grzegorz Kazek ◽  
Monika Głuch-Lutwin ◽  
Barbara Mordyl ◽  
Elżbieta Menaszek ◽  
Janusz Szklarzewicz ◽  
...  

In this study, 110 newly synthesized vanadium complexes from different structural groups were screened in three cell-based models representing the main target tissues for anti-diabetic drugs. In glucose utilization in C2C12 myocyte experiments, 93% of vanadium complexes were shown to have equal or greater activity than bis(maltolato)oxovanadium(IV) (BMOV), the methyl analog of bis(ethylmaltolato)oxovanadium(IV) (BEOV) which has been tested in clinical trials. Moreover, 49% and 50% of these complexes were shown to have equal or greater activity than BMOV in lipid accumulation in 3T3-L1 adipocytes and insulin secretion in RINm5F beta cell experiments, respectively. These results were the basis for the selection of compounds for the subsequent steps in the characterization of anti-diabetic properties. This study provides strong support for the application of screening cell-based assays with a phenotypic approach for the discovery of novel anti-diabetic drugs from the vanadium complex class. This is especially desirable due to the multiple and not fully defined mechanisms of action vanadium compounds.


2018 ◽  
Vol 58 (1) ◽  
pp. 844-854 ◽  
Author(s):  
Eric Steffensmeier ◽  
Matthew T. Swann ◽  
Kenneth M. Nicholas

Sign in / Sign up

Export Citation Format

Share Document